A detailed history of First Turn Management, LLC transactions in Argenx Se stock. As of the latest transaction made, First Turn Management, LLC holds 54,440 shares of ARGX stock, worth $34.8 Million. This represents 4.67% of its overall portfolio holdings.

Number of Shares
54,440
Previous 79,978 31.93%
Holding current value
$34.8 Million
Previous $34.4 Billion 14.2%
% of portfolio
4.67%
Previous 5.59%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$434.22 - $551.9 $11.1 Million - $14.1 Million
-25,538 Reduced 31.93%
54,440 $29.5 Billion
Q1 2024

May 03, 2024

SELL
$356.95 - $413.29 $1.22 Million - $1.42 Million
-3,425 Reduced 4.11%
79,978 $31.5 Billion
Q4 2023

Feb 07, 2024

BUY
$338.91 - $506.01 $28.3 Million - $42.2 Million
83,403 New
83,403 $31.7 Billion

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $35.3B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.